{
    "id": 4689,
    "fullName": "PIK3CB mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CB mut indicates an unspecified mutation within the PIK3CB gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 5291,
        "geneSymbol": "PIK3CB",
        "terms": [
            "PIK3CB",
            "P110BETA",
            "PI3K",
            "PI3KBETA",
            "PIK3C1"
        ]
    },
    "variant": "mutant",
    "createDate": "04/12/2015",
    "updateDate": "04/29/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12127,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, two patients with castration-resistant prostate cancer harboring PIK3CB mutations demonstrated durable clinical benefit when treated with GSK2636771 (PMID: 28645941).",
            "molecularProfile": {
                "id": 4485,
                "profileName": "PIK3CB mutant"
            },
            "therapy": {
                "id": 765,
                "therapyName": "GSK2636771",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 10101,
                    "pubMedId": 28645941,
                    "title": "A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28645941"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 4485,
            "profileName": "PIK3CB mutant",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}